Clark S C
Genetics Institute, Cambridge, Massachusetts 02140.
Int J Cell Cloning. 1988 Nov;6(6):365-77. doi: 10.1002/stem.5530060602.
Granulocyte-macrophage colony-stimulating factor (GM-CSF) has emerged as an important regulation for hematopoietic cell development and function. Within the myeloid lineages, GM-CSF serves as a growth and developmental factor for intermediate-stage progenitors between early, interleukin 3-responsive and late granulocyte colony-stimulating factor-responsive precursors. GM-CSF also serves as an activator of circulating effector cells. The ability of GM-CSF to induce monocyte expression of tumor necrosis factor, interleukin 1 and other factors, further ties this hormone into a network of cytokines that interact to regulate many hematologic and immunologic responses. The availability of large quantities of recombinant GM-CSF now provides the opportunity and challenge not only for unraveling the mechanisms regulating hematopoiesis, but also for developing new therapies for enhancement of host defense against infection that were not previously possible.
粒细胞-巨噬细胞集落刺激因子(GM-CSF)已成为造血细胞发育和功能的重要调节因子。在髓系谱系中,GM-CSF作为早期白介素3反应性和晚期粒细胞集落刺激因子反应性前体之间中间阶段祖细胞的生长和发育因子。GM-CSF还作为循环效应细胞的激活剂。GM-CSF诱导单核细胞表达肿瘤坏死因子、白介素1和其他因子的能力,进一步将这种激素纳入一个细胞因子网络,这些细胞因子相互作用以调节许多血液学和免疫学反应。现在大量重组GM-CSF的可得性不仅为阐明调节造血的机制提供了机会和挑战,也为开发增强宿主抗感染防御的新疗法提供了机会和挑战,而这在以前是不可能的。